chr16-56865236-A-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1PS1_ModeratePM2PP5_Moderate
The NM_001126108.2(SLC12A3):c.1A>G(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.000000684 in 1,461,224 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 6.8e-7 ( 0 hom. )
Consequence
SLC12A3
NM_001126108.2 start_lost
NM_001126108.2 start_lost
Scores
6
6
4
Clinical Significance
Conservation
PhyloP100: 6.36
Genes affected
SLC12A3 (HGNC:10912): (solute carrier family 12 member 3) This gene encodes a renal thiazide-sensitive sodium-chloride cotransporter that is important for electrolyte homeostasis. This cotransporter mediates sodium and chloride reabsorption in the distal convoluted tubule. Mutations in this gene cause Gitelman syndrome, a disease similar to Bartter's syndrome, that is characterized by hypokalemic alkalosis combined with hypomagnesemia, low urinary calcium, and increased renin activity associated with normal blood pressure. This cotransporter is the target for thiazide diuretics that are used for treating high blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PS1
Another start lost variant in NM_001126108.2 (SLC12A3) was described as [Pathogenic] in ClinVar as 945564
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-56865236-A-G is Pathogenic according to our data. Variant chr16-56865236-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 1684155.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC12A3 | NM_001126108.2 | c.1A>G | p.Met1? | start_lost | 1/26 | ENST00000563236.6 | |
SLC12A3 | NM_000339.3 | c.1A>G | p.Met1? | start_lost | 1/26 | ||
SLC12A3 | NM_001126107.2 | c.1A>G | p.Met1? | start_lost | 1/26 | ||
SLC12A3 | NM_001410896.1 | c.1A>G | p.Met1? | start_lost | 1/26 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC12A3 | ENST00000563236.6 | c.1A>G | p.Met1? | start_lost | 1/26 | 1 | NM_001126108.2 | A1 | |
SLC12A3 | ENST00000438926.6 | c.1A>G | p.Met1? | start_lost | 1/26 | 1 | A1 | ||
SLC12A3 | ENST00000566786.5 | c.1A>G | p.Met1? | start_lost | 1/26 | 1 | P4 | ||
SLC12A3 | ENST00000262502.5 | c.1A>G | p.Met1? | start_lost | 1/26 | 5 | A1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248774Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134894
GnomAD3 exomes
AF:
AC:
1
AN:
248774
Hom.:
AF XY:
AC XY:
1
AN XY:
134894
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461224Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726932
GnomAD4 exome
AF:
AC:
1
AN:
1461224
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
726932
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Familial hypokalemia-hypomagnesemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | European Hospital Georges Pompidou Genetics Department, Assistance Publique - Hôpitaux de Paris AP-HP | Apr 27, 2022 | ACMG criteria used: PVS1, PS1, PM1, PM2, PM5 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
D
MutationTaster
Benign
D;D;D;D
PROVEAN
Benign
N;N;N;N
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;D
Sift4G
Benign
T;T;T;T
Polyphen
D;D;P;.
Vest4
MutPred
Loss of solvent accessibility (P = 0.1301);Loss of solvent accessibility (P = 0.1301);Loss of solvent accessibility (P = 0.1301);Loss of solvent accessibility (P = 0.1301);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at